Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Category Archives: Public Health

Subscribe to Public Health RSS Feed

FDA won’t say which drugs on the market were approved based on fraudulent research

Posted in Drug Studies, FDA Regulation

This shows that the FDA is more interested in protecting pharmaceutical companies than patients.  Note how Woodcock doesn’t want to force new trials because that requires human experimentation, which has risk.  A smarter regulator would realize that the risks increase in proportion to the size of the user base of the drug.  And allowing any… Continue Reading

FDA Requires Warning Label Update for Mirena

Posted in Mirena, Recalls

In May of 2008, the United States Food and Drug Administration required that the warning label for Bayer Pharmaceutical’s Mirena intrauterine contraceptive device be updated to include information regarding the risk for uterine perforation and Mirena migration as a result of then-recent research. Read the FDA-mandated warning update for Mirena here. Currently, Mirena is the world’s most… Continue Reading

New Bill Would Force Retailers To Notify Consumers of Recalls

Posted in Recalls

If you’re like me, you have a couple of “frequent shopper” cards in your wallet that give you discounts at the grocery stores you frequent.  You probably already know that those frequent shopper cards enable retailers to track every purchase you make.  And you probably already know that retailers get notified by the FDA when… Continue Reading

Premium Edge Cat Food Recalled

Posted in Recalls, Safety Alerts

If you have a furry little friend who eats Premium Edge cat food, you’ll want to read this: On September 23, Diamond Pet Foods issued a voluntary recall for Premium Edge Finicky Adult Cat and Premium Edge Hairball cat because they have the potential to produce Thiamine Deficiency. Today’s announcement provides additional information from the… Continue Reading

New Warning for Users of Meridia

Posted in Misc. Drugs, Safety Alerts

This is fresh from the FDA.  If you’re using Meridia (Sibutramine) you may want to bring this up with your doctor: FDA notified healthcare professionals and patients that it is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of cardiovascular events (heart attack, stroke, resuscitated cardiac arrest,… Continue Reading

New Information About Drugs Used In Shoulder Pain Pumps

Posted in Misc. Drugs, Safety Alerts

One area I haven’t written much about yet is the association of chrondrolysis with drugs used in certain shoulder pain pumps.  Here’s some fresh information on that topic from the FDA: FDA notified healthcare professionals of 35 reports of chondrolysis (necrosis and destruction of cartilage) in patients given continuous intra-articular infusions of local anesthetics with… Continue Reading

Some Lots of Vicks Sinex Nasal Spray Recalled

Posted in Safety Alerts

If you have any Sinex Nasal Spray, you should check to make sure it’s not one of the recalled bottles: Procter & Gamble and FDA notified consumers of a voluntary recall of three lots of Vicks Sinex Nasal Spray in the United States, Germany and the United Kingdom. The bacteria B. cepacia was found in… Continue Reading

Do you take Plavix and Prevacid? Then read this warning.

Posted in Safety Alerts

Fresh from the FDA a few minutes ago… [Posted 11/17/2009] FDA notified healthcare professionals of new safety information concerning an interaction between clopidogrel (Plavix), an anti-clotting medication, and omeprazole (Prilosec/Prilosec OTC), a proton pump inhibitor (PPI) used to reduce stomach acid.  New data show that when clopidogrel and omeprazole are taken together, the effectiveness of… Continue Reading

News about link between Byetta and acute renal failure

Posted in Safety Alerts

Just got this in my email from the FDA: Byetta (exenatide) – Renal Failure Audience: Endocrine and nephrology healthcare professionals FDA notified healthcare professionals of revisions to the prescribing information for Byetta (exenatide) to include information on post-marketing reports of altered kidney function, including acute renal failure and insufficiency. Byetta, an incretin-mimetic, is approved as… Continue Reading

New study shows risk of weight gain for users of antipsychotic drugs

Posted in Drug Studies

More evidence that certain drugs can cause diabetes… Young children and adolescents who take the newest generation of antipsychotic medications risk rapid weight gain and metabolic changes that could lead to diabetes, hypertension and other illnesses, according to the biggest study yet of first-time users of the drugs. The study, to be published Wednesday in… Continue Reading

Rituxan and progressive multifocal leukoencephalopathy

Posted in Safety Alerts

From the FDA: Genentech and FDA notified healthcare professionals about a third case of progressive multifocal leukoencephalopathy [PML], the first case of PML in a patient with rheumatoid arthritis [RA] treated with Rituxan who has not previously received treatment with a TNF antagonist. Information to date suggests that patients with RA who receive Rituxan have… Continue Reading

Warning About Iron Dextran Injections

Posted in Misc. Drugs, Safety Alerts

I don’t always post FDA alerts, but when one involves possible fatalities, I do. [Posted 10/16/2009] American Regent and FDA notified healthcare professionals that anaphylactic-type reactions, including fatalities, have followed the parenteral administration of iron dextran injection. The Boxed Warning has been modified to recommend administering a test dose prior to the first therapeutic dose… Continue Reading

Complete List of Recalled Children’s Tylenol

Posted in Recalls

You’ve probably heard that Children’s Tylenol was recalled earlier this month.  Fresh from the FDA, here’s the complete list of all products that were recalled.  If you have any of them, DON’T USE THEM. 1) Children's Tylenol Plus, Multi-Symptom Cold, (each 5 mL contains: Acetaminophen 160 mg, Chlorpheniramine maleate 1 mg, Dextromethorphan HBr 5 mg,… Continue Reading

FDA Issues Warning on Progressive Multifocal Leukoencephalopathy (PML) and Tysabri

Posted in Misc. Drugs, Safety Alerts

Do you subscribe to FDA warning alerts?  Well, if not, you should.  Because if you did you’d get informative emails like this one: Audience: Neurological healthcare professionals, patients [Posted 09/17/2009] FDA continues to receive reports of progressive multifocal leukoencephalopathy (PML) in patients receiving Tysabri.  Tysabri was approved by the FDA for the treatment of relapsing… Continue Reading

More Fentanyl patches recalled – not Duragesic this time

Posted in Duragesic / Fentanyl, Recalls

Watson Pharmaceuticals has announced a recall of all 75mcg Fentanyl patches from lot number 92461850.  These patches are being recalled for the same reason many of Johnson & Johnson’s Duragesic patches were recalled: Manufacturing defects that could lead to leakage.  Here’s an excerpt from Watson’s press release: CORONA, CA – August 8, 2008 – Watson… Continue Reading